A PSMA scan is a nuclear medicine imaging technique used in the diagnosis and staging of prostate cancer. It is carried out by injection of a radiopharmaceutical...
21 KB (1,944 words) - 06:03, 2 May 2025
'gallium scan'. Usually they are named after the addressed target or labeled bioligand, e.g., 'PSMA scan' or 'DOTATOC scan'. In the past, the gallium scan was...
35 KB (3,570 words) - 23:01, 10 March 2025
(worst prognosis). The extent of cancer spread is assessed by MRI or PSMA scan – a positron emission tomography (PET) imaging technique where a radioactive...
81 KB (9,190 words) - 23:48, 20 May 2025
Gallium (68Ga) gozetotide (redirect from Gallium 68 PSMA-11)
Gallium (68Ga) gozetotide or Gallium (68Ga) PSMA-11, sold under the brand name Illuccix among others, is a radiopharmaceutical made of 68Ga conjugated...
19 KB (1,345 words) - 05:14, 17 April 2025
pulmonary indications. 177Lu-PSMA-617 and 68Ga-PSMA-617 are in development to treat, image, monitor and stage prostate cancer. PSMA-617 is a ligand of prostate-specific...
20 KB (1,768 words) - 18:07, 12 September 2024
of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE". EJNMMI Radiopharmacy and Chemistry. 6 (1): 1. doi:10...
17 KB (1,251 words) - 17:15, 31 March 2025
randomised phase 3 trial ("ProPSMA study") was published comparing Gallium-68 PSMA PET/CT to standard imaging (CT and bone scan). This 300 patient study conducted...
36 KB (4,317 words) - 06:21, 12 May 2025
It is the second PSMA-targeted PET imaging drug approved by the U.S. Food and Drug Administration (FDA). The first approved PSMA-targeted PET imaging...
11 KB (833 words) - 04:22, 24 December 2024
mAbs and PSMA-targeted PET imaging, they accurately identified cancer spread. Their work laid the foundation for the now standard PSMA PET scan. They were...
13 KB (1,193 words) - 00:50, 16 May 2025
the PSMA radioligand therapy (Pluvicto) requires the patient to have end-stage prostate cancer that has metastasized in other organs, the PSMA ligand...
35 KB (4,347 words) - 21:17, 21 April 2025
Yongxiang; Yin, Hongling; Hu, Shuo (2021). "18F-PSMA-1007 PET/CT uptake in multiple angiolipomas caused by PSMA expression in capillaries: a case report"....
12 KB (1,159 words) - 12:35, 23 October 2024
dosimetry estimates prior to 90Y immunotherapy for lymphoma 111In ProstaScint — PSMA antibody imaging of prostate cancer 111In pentetreotide (including in 111In...
6 KB (536 words) - 00:30, 6 September 2024
Flamen P (May 2017). "Vertebral Hemangioma Mimicking Bone Metastasis in 68Ga-PSMA Ligand PET/CT". Clinical Nuclear Medicine. 42 (5): 368–370. doi:10.1097/RLU...
15 KB (1,520 words) - 15:00, 19 February 2025
Emmett L, Willowson K, Violet J, Shin J, Blanksby A, Lee J (March 2017). "177 PSMA radionuclide therapy for men with prostate cancer: a review of the current...
13 KB (1,205 words) - 22:35, 3 December 2023
period to prepare the radiopharmaceutical and trace it, such as a fibrinogen scan to diagnose clotting. I-125's gamma radiation is of medium penetration, making...
20 KB (673 words) - 08:23, 17 January 2024
Excellence. 29 August 2018. Retrieved 3 September 2018. Kabasaka, Levent. "Lu-177-PSMA Real World Clinical Study: Out-patient or In-patient Treatment" (PDF). BNMS...
28 KB (2,914 words) - 02:17, 16 July 2024
they can be visualized clearly using prostate-specific membrane antigen (PSMA) positron emission tomography—computed tomography (PET/CT). The glands were...
5 KB (507 words) - 15:11, 21 May 2025
Positron-emitting and Fluorescent (HD-GPF) reporter system uses a human protein, PSMA and non-immunogenic, and a small molecule that is positron-emitting (boron...
47 KB (6,058 words) - 20:47, 21 February 2025
177Lu-PSMA or 225Ac-PSMA therapies. For local recurrence, 68Ga-PSMA PET/MR or PET/CT in combination with mpMR is most appropriate. PSMA PET/CT may be potentially...
47 KB (5,367 words) - 23:55, 6 March 2025
Nitin; El-Haddad, Ghassan; Park, Chandler H. (June 23, 2021). "Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer". New England Journal...
31 KB (2,814 words) - 20:17, 25 October 2024
Leonardo Lima; Lemos, Gustavo Caserta (2020-02-24). "Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate...
17 KB (2,147 words) - 15:52, 17 September 2022
treatment. Results from Phase 2 trial recommended G-202 as a first-in-class PSMA-targeted prodrug and that it move to clinical trials. Current research includes...
94 KB (10,606 words) - 14:38, 11 May 2025
location intelligence tool, called GeoVision, which uses data provided by PSMA Australia and allows companies to "visualise, analyse, and ultimately make...
60 KB (5,458 words) - 02:12, 11 March 2025
diagnostics. Mirzaei and his team are the first center which is applying Cu-64 PSMA in prostate cancer. Somatostatin receptor scintigraphy (SRS) and therapy...
15 KB (1,942 words) - 16:45, 18 February 2023
resources. Since 2017, he steered the development of [68Ga]Ga-/[177Lu]Lu-PSMA-based theranostics and peptide receptor radioligand therapy (PRLT) in metastatic...
24 KB (2,622 words) - 03:25, 24 January 2025